Terms: = Kidney tumors AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Diagnosis
22 results:
1. Pediatric BCOR-Altered tumors From Soft Tissue/kidney Display Specific DNA Methylation Profiles.
Salgado CM; Alaggio R; Ciolfi A; Zin A; Diomedi Camassei F; Pedace L; Milano GM; Serra A; Di Giannatale A; Mastronuzzi A; Gianatti A; Bisogno G; Ferrari A; Tartaglia M; Reyes-Múgica M; Locatelli F; Miele E
Mod Pathol; 2023 Feb; 36(2):100039. PubMed ID: 36853789
[TBL] [Abstract] [Full Text] [Related]
2. Clinical relevance of BCOR internal tandem duplication and TP53 aberration in clear cell sarcoma of the kidney.
Zhang M; Yao X; Guan X; Jia C; Zhang R; Wang H; Guo Y; Ni X; Yu Y; He L
Hum Pathol; 2023 Apr; 134():45-55. PubMed ID: 36563883
[TBL] [Abstract] [Full Text] [Related]
3. Clear Cell Sarcoma of the kidney (CCSK) With
Dorwal P; Abou-Seif C; Ng J; Super L; Chan Y; Rathi V
Pediatr Dev Pathol; 2023; 26(2):149-152. PubMed ID: 36533315
[TBL] [Abstract] [Full Text] [Related]
4. [Morphological diagnosis of childhood bone marrow failure syndromes].
Hama A
Rinsho Ketsueki; 2022; 63(9):1035-1041. PubMed ID: 36198526
[TBL] [Abstract] [Full Text] [Related]
5. Paediatric BCOR-associated sarcomas with a novel long spliced internal tandem duplication of BCOR exon 15.
Goh JY; Kuick CH; Sugiura M; Aw SJ; Zhao M; Tang H; Gunaratne S; Zhu F; Cai L; Teh BT; Thorner PS; Chang KTE
J Pathol Clin Res; 2022 Sep; 8(5):470-480. PubMed ID: 35836306
[TBL] [Abstract] [Full Text] [Related]
6. Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System.
Waters AM; Park HJ; Weskamp AL; Mateja A; Kachur ME; Lyons JJ; Rosen BJ; Boggs NA
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2424-2435.e5. PubMed ID: 35032694
[TBL] [Abstract] [Full Text] [Related]
7. Sclerosing Extramedullary Hematopoietic Tumor: A Case Report.
Wang D; Castro E; Rao A; McPhaul CM
J Investig Med High Impact Case Rep; 2020; 8():2324709620956463. PubMed ID: 32911987
[TBL] [Abstract] [Full Text] [Related]
8. Undifferentiated round cell sarcoma with BCOR internal tandem duplications (ITD) or ywhae fusions: a clinicopathologic and molecular study.
Antonescu CR; Kao YC; Xu B; Fujisawa Y; Chung C; Fletcher CDM; Graf N; Suurmeijer AJ; Zin A; Wexler LH; Ferrari A; Bisogno G; Alaggio R
Mod Pathol; 2020 Sep; 33(9):1669-1677. PubMed ID: 32372022
[TBL] [Abstract] [Full Text] [Related]
9. Immunophenotype-Genotype Correlations in Clear Cell Sarcoma of kidney-An Evaluation of Diagnostic Ancillary Studies.
Kenny C; Grehan D; Ulas M; Banga GB; Coulomb A; Vokuhl C; O'Sullivan MJ
Pediatr Dev Pathol; 2020; 23(5):345-351. PubMed ID: 32364435
[TBL] [Abstract] [Full Text] [Related]
10. Clear Cell Sarcoma of the kidney.
Aldera AP; Pillay K
Arch Pathol Lab Med; 2020 Jan; 144(1):119-123. PubMed ID: 30917048
[TBL] [Abstract] [Full Text] [Related]
11. Clear Cell Sarcoma of the kidney.
Aw SJ; Chang KTE
Arch Pathol Lab Med; 2019 Aug; 143(8):1022-1026. PubMed ID: 30628851
[TBL] [Abstract] [Full Text] [Related]
12. Increasing therapy-related myeloid neoplasms in multiple myeloma.
Fernández-Caballero M; Salmerón D; Dolores Chirlaque M; Chen-Liang TH; Hurtado AM; García Malo MD; Ortuño FJ; Roldán V; Vicente V; Jerez A; De Arriba F
Eur J Clin Invest; 2019 Feb; 49(2):e13050. PubMed ID: 30422316
[TBL] [Abstract] [Full Text] [Related]
13. Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?
Shenoy N; Mudireddy M; Vallapureddy R; Leung N; Pagliaro L; Witzig T; Ou FS; Ordog T; Cheville J; Patnaik M; Thompson RH; Tefferi A; Begna K
Clin Genitourin Cancer; 2018 Dec; 16(6):e1117-e1122. PubMed ID: 30077464
[TBL] [Abstract] [Full Text] [Related]
14. Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases.
Wu B; Ingersoll K; Jug R; Yang LH; Luedke C; Lo A; Su P; Liu X; Rehder C; Gong J; Lu CM; Wang E
Am J Clin Pathol; 2017 Dec; 149(1):55-66. PubMed ID: 29228125
[TBL] [Abstract] [Full Text] [Related]
15. BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities.
Kao YC; Sung YS; Zhang L; Jungbluth AA; Huang SC; Argani P; Agaram NP; Zin A; Alaggio R; Antonescu CR
Am J Surg Pathol; 2016 Dec; 40(12):1670-1678. PubMed ID: 27428733
[TBL] [Abstract] [Full Text] [Related]
16. Radiotherapy- and chemotherapy-induced myelodysplasia syndrome: a nationwide population-based nested case-control study.
Sun LM; Lin CL; Lin MC; Liang JA; Kao CH
Medicine (Baltimore); 2015 May; 94(17):e737. PubMed ID: 25929909
[TBL] [Abstract] [Full Text] [Related]
17. Novel Karyotypes and Cyclin D1 Immunoreactivity in Clear Cell Sarcoma of the kidney.
Jet Aw S; Hong Kuick C; Hwee Yong M; Wen Quan Lian D; Wang S; Liang Loh AH; Ling S; Lian Peh G; Yen Soh S; Pheng Loh AH; Hoon Tan P; Tou En Chang K
Pediatr Dev Pathol; 2015; 18(4):297-304. PubMed ID: 25751590
[TBL] [Abstract] [Full Text] [Related]
18. Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney.
Mirkovic J; Calicchio M; Fletcher CD; Perez-Atayde AR
Histopathology; 2015 Sep; 67(3):306-12. PubMed ID: 25556515
[TBL] [Abstract] [Full Text] [Related]
19. Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome.
Della Porta MG; Malcovati L; Strupp C; Ambaglio I; Kuendgen A; Zipperer E; Travaglino E; Invernizzi R; Pascutto C; Lazzarino M; Germing U; Cazzola M
Haematologica; 2011 Mar; 96(3):441-9. PubMed ID: 21134982
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients.
Breccia M; Federico V; Latagliata R; Mercanti C; D'Elia GM; Cannella L; Loglisci G; Salaroli A; Santopietro M; Alimena G
Leuk Res; 2011 Feb; 35(2):159-62. PubMed ID: 20594593
[TBL] [Abstract] [Full Text] [Related]
[Next]
